Kirkland & Ellis advised Thoma Bravo, while Goodwin Procter advised SailPoint Technologies Holdings, Inc. on the deal. Latham & Watkins represented the direct lenders in the...
You must be a Standard 1 Year member to access this content.
Wiggin and Dana LLP represented Exela Technologies, Inc. on the matter while Goodwin Procter advised UBERDOC. Exela Technologies, Inc. (NASDAQ: XELA), a global business process automation (BPA) leader, announced a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Bregal Sagemount on the deal. Bregal Sagemount announced its strategic investment in DentalXChange. Together the firms are eyeing robust strategic growth led by a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Bio Products Laboratory and Tiancheng International Investment Limited on the deal. The shareholders of Kedrion was advised by Carnelutti and Pedersoli Studio Legale,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Human Care Systems on the deal. Human Care Systems, Inc. announced its sale to CareMetx, LLC. Human Care Systems is a company focused on...
You must be a Standard 1 Year member to access this content.
Goodwin advised Aldrich Capital Partners on the deal. Aldrich Capital Partners announced its acquisition of Compliancy Group, LLC. Aldrich is a growth equity firm supporting disruptive innovation...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Aldrich Capital Partners on the deal. Aldrich Capital Partners announced its acquisition of PRIA Healthcare Management. Aldrich is a growth equity firm supporting disruptive...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Elligo Health Research on the deal while Holland & Knight represented Morgan Stanley Expansion Capital and Ally Bridge Group. Elligo Health Research announced its...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Baker McKenzie advised Trillium Therapeutics on the deal, while Ropes & Gray LLP and Norton Rose Fulbright Canada represented Pfizer. Trillium Therapeutics (NASDAQ/TSX:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP and JunHe advised Goldman Sachs & Co. LLC and the other underwriters on the deal, while Wilson Sonsini Goodrich & Rosati and Maples...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised the underwriters on the deal, while Dechert advised Femasys. Chardan, a global investment bank, announced that it acted as lead left bookrunner in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Goodwin Procter LLP advised Centessa Pharmaceuticals on the deal. Centessa Pharmaceuticals, a clinical-stage company employing its innovative asset-centric business model...
You must be a Standard 1 Year member to access this content.
